Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype

Cell

Volumn 163, Issue 5, 2015, Pages 1204-1213

  Vieira, Natassia M ^a,b,c   Elvers, Ingegerd ^d,e   Alexander, Matthew S ^a,b   Moreira, Yuri B ^c   Eran, Alal ^b   Gomes, Juliana P ^c   Marshall, Jamie L ^a,b   Karlsson, Elinor K ^d,g   Verjovski Almeida, Sergio ^c,f   Lindblad Toh, Kerstin ^d,e   Kunkel, Louis M ^a,b   Zatz, Mayana ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e UPPSALA UNIVERSITY   (Sweden)

^f INSTITUTO BUTANTAN   (Brazil)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

DMD; dystrophin; genetic modifier; Jagged1; muscle

Indexed keywords

DYSTROPHIN; JAGGED1; JAGGED1A PROTEIN; JAGGED1B PROTEIN; MYOD PROTEIN; MYOGENIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; JAG1 PROTEIN, HUMAN; JAG1 PROTEIN, MOUSE; JAG1 PROTEIN, ZEBRAFISH; MEMBRANE PROTEIN; PROTEIN JAGGED 1; SERRATE JAGGED PROTEIN; SIGNAL PEPTIDE; ZEBRAFISH PROTEIN;

ANIMAL TISSUE; ARTICLE; BIREFRINGENCE; CELL PROLIFERATION; CHROMOSOME; CHROMOSOME 24; CHROMOSOME 33; CHROMOSOME 37; CONTROLLED STUDY; DOG DISEASE; DUCHENNE MUSCULAR DYSTROPHY; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; GENETIC LINKAGE; GENETIC VARIABILITY; GOLDEN RETRIEVER; GOLDEN RETRIEVER MUSCULAR DYSTROPHY; HAPLOTYPE; HUMAN; HUMAN CELL; LIFESPAN; LINKAGE ANALYSIS; LUCIFERASE ASSAY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; OLIGONUCLEOTIDE PROBE; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEGREGATION ANALYSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TIBIALIS ANTERIOR MUSCLE; UPREGULATION; WILD TYPE; ZEBRA FISH; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; DEFICIENCY; DISEASE MODEL; DOG; FEMALE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALE; PENETRANCE;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; DYSTROPHIN; FEMALE; GENOME-WIDE ASSOCIATION STUDY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAGGED-1 PROTEIN; MALE; MEMBRANE PROTEINS; MICE; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; PEDIGREE; PENETRANCE; SERRATE-JAGGED PROTEINS; TRANSCRIPTOME; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84947793689     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.10.049     Document Type: Article

References (55)

1. G.R. Abecasis, S.S. Cherny, W.O. Cookson, and L.R. Cardon Merlin - rapid analysis of dense genetic maps using sparse gene flow trees Nat. Genet. 30 2002 97 101
2. E. Axelsson, A. Ratnakumar, M.L. Arendt, K. Maqbool, M.T. Webster, M. Perloski, O. Liberg, J.M. Arnemo, A. Hedhammar, and K. Lindblad-Toh The genomic signature of dog domestication reveals adaptation to a starch-rich diet Nature 495 2013 360 364
3. D. Bassett, and P.D. Currie Identification of a zebrafish model of muscular dystrophy Clin. Exp. Pharmacol. Physiol. 31 2004 537 540
4. D.I. Bassett, R.J. Bryson-Richardson, D.F. Daggett, P. Gautier, D.G. Keenan, and P.D. Currie Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo Development 130 2003 5851 5860
5. L. Bello, L. Piva, A. Barp, A. Taglia, E. Picillo, G. Vasco, M. Pane, S.C. Previtali, Y. Torrente, E. Gazzerro, and et al. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy Neurology 79 2012 159 162
6. C.R. Bjornson, T.H. Cheung, L. Liu, P.V. Tripathi, K.M. Steeper, and T.A. Rando Notch signaling is necessary to maintain quiescence in adult muscle stem cells Stem Cells 30 2012 232 242
7. S.R. Browning, and B.L. Browning Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering Am. J. Hum. Genet. 81 2007 1084 1097
8. G. Bulfield, W.G. Siller, P.A. Wight, and K.J. Moore X chromosome-linked muscular dystrophy (mdx) in the mouse Proc. Natl. Acad. Sci. USA 81 1984 1189 1192
9. K. Bushby, R. Finkel, D.J. Birnkrant, L.E. Case, P.R. Clemens, L. Cripe, A. Kaul, K. Kinnett, C. McDonald, S. Pandya, et al. DMD Care Considerations Working Group Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care Lancet Neurol. 9 2010 177 189
10. M. Castro-Gago Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin Neuromuscul. Disord. 25 2015 443
11. V.M. Chapman, D.R. Miller, D. Armstrong, and C.T. Caskey Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice Proc. Natl. Acad. Sci. USA 86 1989 1292 1296
12. J.E. Church, J. Trieu, A. Chee, T. Naim, S.M. Gehrig, S. Lamon, C. Angelini, A.P. Russell, and G.S. Lynch Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy Exp. Physiol. 99 2014 675 687
13. C. Collesi, L. Zentilin, G. Sinagra, and M. Giacca Notch1 signaling stimulates proliferation of immature cardiomyocytes J. Cell Biol. 183 2008 117 128
14. I.M. Conboy, and T.A. Rando The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis Dev. Cell 3 2002 397 409
15. I.M. Conboy, M.J. Conboy, G.M. Smythe, and T.A. Rando Notch-mediated restoration of regenerative potential to aged muscle Science 302 2003 1575 1577
16. B.J. Cooper, N.J. Winand, H. Stedman, B.A. Valentine, E.P. Hoffman, L.M. Kunkel, M.O. Scott, K.H. Fischbeck, J.N. Kornegay, R.J. Avery, and et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs Nature 334 1988 154 156
17. R. Couteaux, J.C. Mira, and A. d'Albis Regeneration of muscles after cardiotoxin injury. I. Cytological aspects Biol. Cell 62 1988 171 182
18. Y. Dong, T. Long, C. Wang, A.J. Mirando, J. Chen, R.J. O'Keefe, and M.J. Hilton NOTCH-Mediated Maintenance and Expansion of Human Bone Marrow Stromal/Stem Cells: A Technology Designed for Orthopedic Regenerative Medicine Stem Cells Transl. Med. 3 2014 1456 1466
19. R.J. Fairclough, M.J. Wood, and K.E. Davies Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches Nat. Rev. Genet. 14 2013 373 378
20. K.M. Flanigan, E. Ceco, K.M. Lamar, Y. Kaminoh, D.M. Dunn, J.R. Mendell, W.M. King, A. Pestronk, J.M. Florence, K.D. Mathews, et al. United Dystrophinopathy Project LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy Ann. Neurol. 73 2013 481 488
21. N.M. Goemans, M. Tulinius, J.T. van den Akker, B.E. Burm, P.F. Ekhart, N. Heuvelmans, T. Holling, A.A. Janson, G.J. Platenburg, J.A. Sipkens, and et al. Systemic administration of PRO051 in Duchenne's muscular dystrophy N. Engl. J. Med. 364 2011 1513 1522
22. S. Guiraud, A. Aartsma-Rus, N.M. Vieira, K.E. Davies, G.J. van Ommen, and L.M. Kunkel The Pathogenesis and Therapy of Muscular Dystrophies Annu. Rev. Genomics Hum. Genet. 16 2015 281 308
23. A. Heydemann, K.A. Swaggart, G.H. Kim, J. Holley-Cuthrell, M. Hadhazy, and E.M. McNally The superhealing MRL background improves muscular dystrophy Skelet. Muscle 2 2012 26
24. M.P. Hoeppner, A. Lundquist, M. Pirun, J.R. Meadows, N. Zamani, J. Johnson, G. Sundström, A. Cook, M.G. FitzGerald, R. Swofford, and et al. An improved canine genome and a comprehensive catalogue of coding genes and non-coding transcripts PLoS ONE 9 2014 e91172
25. E.P. Hoffman, R.H. Brown Jr., and L.M. Kunkel Dystrophin: the protein product of the Duchenne muscular dystrophy locus Cell 51 1987 919 928
26. W.B. Im, S.F. Phelps, E.H. Copen, E.G. Adams, J.L. Slightom, and J.S. Chamberlain Differential expression of dystrophin isoforms in strains of mdx mice with different mutations Hum. Mol. Genet. 5 1996 1149 1153
27. C. Jiang, Y. Wen, K. Kuroda, K. Hannon, M.A. Rudnicki, and S. Kuang Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy Dis. Model. Mech. 7 2014 997 1004
28. H.M. Kang, J.H. Sul, S.K. Service, N.A. Zaitlen, S.Y. Kong, N.B. Freimer, C. Sabatti, and E. Eskin Variance component model to account for sample structure in genome-wide association studies Nat. Genet. 42 2010 348 354
29. R. Kayali, J.M. Ku, G. Khitrov, M.E. Jung, O. Prikhodko, and C. Bertoni Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy Hum. Mol. Genet. 21 2012 4007 4020
30. M. Koenig, A.H. Beggs, M. Moyer, S. Scherpf, K. Heindrich, T. Bettecken, G. Meng, C.R. Müller, M. Lindlöf, H. Kaariainen, and et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion Am. J. Hum. Genet. 45 1989 498 506
31. J.N. Kornegay, S.M. Tuler, D.M. Miller, and D.C. Levesque Muscular dystrophy in a litter of golden retriever dogs Muscle Nerve 11 1988 1056 1064
32. C.E. Lindsell, C.J. Shawber, J. Boulter, and G. Weinmaster Jagged: a mammalian ligand that activates Notch1 Cell 80 1995 909 917
33. T. Manke, M. Heinig, and M. Vingron Quantifying the effect of sequence variation on regulatory interactions Hum. Mutat. 31 2010 477 483
34. V. Matys, O.V. Kel-Margoulis, E. Fricke, I. Liebich, S. Land, A. Barre-Dirrie, I. Reuter, D. Chekmenev, M. Krull, K. Hornischer, and et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes Nucleic Acids Res. 34 2006 D108 D110
35. J.R. Mendell, K. Campbell, L. Rodino-Klapac, Z. Sahenk, C. Shilling, S. Lewis, D. Bowles, S. Gray, C. Li, G. Galloway, and et al. Dystrophin immunity in Duchenne's muscular dystrophy N. Engl. J. Med. 363 2010 1429 1437
36. J.R. Mendell, C. Shilling, N.D. Leslie, K.M. Flanigan, R. al-Dahhak, J. Gastier-Foster, K. Kneile, D.M. Dunn, B. Duval, A. Aoyagi, and et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy Ann. Neurol. 71 2012 304 313
37. J.R. Mendell, L.R. Rodino-Klapac, Z. Sahenk, K. Roush, L. Bird, L.P. Lowes, L. Alfano, A.M. Gomez, S. Lewis, J. Kota, et al. Eteplirsen Study Group Eteplirsen for the treatment of Duchenne muscular dystrophy Ann. Neurol. 74 2013 637 647
38. A.P. Monaco, C.J. Bertelson, S. Liechti-Gallati, H. Moser, and L.M. Kunkel An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus Genomics 2 1988 90 95
39. X. Mu, Y. Tang, A. Lu, K. Takayama, A. Usas, B. Wang, K. Weiss, and J. Huard The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy Hum. Mol. Genet. 24 2015 2923 2937
40. C. Ottone, B. Krusche, A. Whitby, M. Clements, G. Quadrato, M.E. Pitulescu, R.H. Adams, and S. Parrinello Direct cell-cell contact with the vascular niche maintains quiescent neural stem cells Nat. Cell Biol. 16 2014 1045 1056
41. M.R. Passos-Bueno, M. Vainzof, S.K. Marie, and M. Zatz Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy Hum. Mol. Genet. 3 1994 919 922
42. A.R. Pedrosa, A. Trindade, A.C. Fernandes, C. Carvalho, J. Gigante, A.T. Tavares, R. Diéguez-Hurtado, H. Yagita, R.H. Adams, and A. Duarte Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1 Arterioscler. Thromb. Vasc. Biol. 35 2015 1134 1146
43. E. Pegoraro, E.P. Hoffman, L. Piva, B.F. Gavassini, S. Cagnin, M. Ermani, L. Bello, G. Soraru, B. Pacchioni, M.D. Bonifati, et al. Cooperative International Neuromuscular Research Group SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy Neurology 76 2011 219 226
44. L. Piva, B.F. Gavassini, L. Bello, M. Fanin, G. Soraru, A. Barp, M. Ermani, C. Angelini, E.P. Hoffman, and E. Pegoraro TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle J. Pathol. 228 2012 251 259
45. N.J. Sharp, J.N. Kornegay, S.D. Van Camp, M.H. Herbstreith, S.L. Secore, S. Kettle, W.Y. Hung, C.D. Constantinou, M.J. Dykstra, A.D. Roses, and et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy Genomics 13 1992 115 121
46. P. Sicinski, Y. Geng, A.S. Ryder-Cook, E.A. Barnard, M.G. Darlison, and P.J. Barnard The molecular basis of muscular dystrophy in the mdx mouse: a point mutation Science 244 1989 1578 1580
47. M. Vainzof, R.C. Pavanello, I. Pavanello Filho, M.R. Passos-Bueno, D. Rapaport, C.T. Hsi, and M. Zatz Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study J. Neurol. Sci. 98 1990 221 233
48. J.C. van Deutekom, A.A. Janson, I.B. Ginjaar, W.S. Frankhuizen, A. Aartsma-Rus, M. Bremmer-Bout, J.T. den Dunnen, K. Koop, A.J. van der Kooi, N.M. Goemans, and et al. Local dystrophin restoration with antisense oligonucleotide PRO051 N. Engl. J. Med. 357 2007 2677 2686
49. C. Wellcome Trust Case Control Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 447 2007 661 678
50. Y. Wen, P. Bi, W. Liu, A. Asakura, C. Keller, and S. Kuang Constitutive Notch activation upregulates Pax7 and promotes the self-renewal of skeletal muscle satellite cells Mol. Cell. Biol. 32 2012 2300 2311
51. W.E. Wright, D.A. Sassoon, and V.K. Lin Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD Cell 56 1989 607 617
52. Y. Xiao, D. Gong, and W. Wang Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling Arterioscler. Thromb. Vasc. Biol. 33 2013 2733 2739
53. M. Zatz, R.C. Pavanello, M. Lazar, G.L. Yamamoto, N.C. Lourenço, A. Cerqueira, L. Nogueira, and M. Vainzof Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin Neuromuscul. Disord. 24 2014 986 989
54. M. Zatz, N.M. Vieira, E. Zucconi, M. Pelatti, J. Gomes, M. Vainzof, A.B. Martins-Bach, M.C. Garcia Otaduy, G. Bento dos Santos, E. Amaro Jr., and et al. A normal life without muscle dystrophin Neuromuscul. Disord. 25 2015 371 374
55. E. Zucconi, M.C. Valadares, N.M. Vieira, C.R. Bueno Jr., M. Secco, T. Jazedje, H.C. da Silva, M. Vainzof, and M. Zatz Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog Neuromuscul. Disord. 20 2010 64 70